PharVision Advisers’s Marqeta MQ Stock Holding History

PharVision Advisers’s Portfolio MQ Stock Details MQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,278	Closed	-$309K	–	441
2025 Q4	$309K	Buy	16,278 +10,576	+185%	+$203K	0.16%	253
2025 Q3	$120K	Buy	+5,702	New	+$135K	0.07%	603

Other funds holding MQ

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PharVision Advisers's MQ Position: Q1 2026 in Review

PharVision Advisers sold out of Marqeta (MQ) in Q1 2026, closing a stake of 16,278 shares — an estimated $309K sold.

PharVision Advisers first reported a position in MQ in Q3 2025 and held it in 2 quarters. The position peaked at $309K in Q4 2025. 255 funds tracked by Wall St. Rank hold MQ as of Q1 2026.

PharVision Advisers reported no remaining Marqeta position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 16,278 Marqeta shares in Q1 2026, an estimated $309K.
PharVision Advisers first reported a position in Marqeta in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Marqeta position peaked at $309K in Q4 2025.
255 funds tracked by Wall St. Rank held Marqeta as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.